Effects of inhibition of nitric oxide synthase by aminoguanidine in acute endotoxemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 2 41-2, 1997, Pages

  Hock, Carl E ^a   Yin, Kingsley ^a   Yue, Gang ^a   Wong, Patrick Y K ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

lipopolysaccharide; myeloperoxidase; nitrite nitrate; rat

Indexed keywords

AMINOGUANIDINE; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; HEART FUNCTION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

EID: 33750851120     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.2.h843     Document Type: Article

References (37)

1. Avontuur, J. A. M., H. A. Bruining, and C. Ince. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ. Res. 76: 418-425, 1995.
2. Balligand, J.-L., R. A. Kelly, P. A. Marsden, T. W. Smith, and T. Michel. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA 90: 347-351, 1993.
3. Balligand, J.-L., D. Ungureanu, R. A. Kelly, L. Kobzik, D. Pimental, T. Michel, and T. W. Smith. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 91: 2314-2319, 1993.
4. Belenky, S. N., R. A. Robbins, S. I. Rennard, G. L. Gossman, K. J. Nelson, and I. Rubenstein. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J. Lab. Clin. Med. 122: 388-394, 1993.
5. Bone, R. C. Gram-negative sepsis. Background, clinical features and intervention. Chest 100: 802-808, 1991.
6. Brady, A. J. B., P. A. Poole-Wilson, S. E. Harding, and J. B. Warren. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1963-H1966, 1992.
7. Busse, R., and A. Mulsch. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275: 87-90, 1990.
8. Calver, A., J. Collier, and P. Vallance. Nitric oxide and cardiovascular control. Exp. Physiol. 78: 303-326, 1993.
9. Cherry, P. D., H. A. Omar, K. A. Farrell, J. S. Stuart, and M. S. Wolin. Superoxide anion inhibits cGMP-associated bovine pulmonary arterial relaxation. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1056-H1062, 1990.
10. Corbett, J. A., R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweetland, J. R. Lancaster, J. R. Williamson, and M. L. McDaniel. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556, 1992.
11. Edelstein, D., and M. Brownlee. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41: 26-29, 1992.
12. Finkel, M. S., C. V. Oddis, T. D. Jacob, S. C. Watkins, B. G. Hattler, and R. L. Simmons. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science Wash. DC 257: 387-389, 1992.
13. Geller, D. A., A. K. Nussler, M. DiSilvio, C. J. Lowenstein, R. A. Shapiro, S. C. Wang, R. L. Simmons, and T. R. Billiar. Cytokines, endotoxin and gluccocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90: 522-526, 1991.
14. Griffith, O. W., and D. J. Stuehr. Nitric oxide syntheses: properties and catalytic mechanism. Annu. Rev. Physiol. 57: 707-736, 1995.
15. Griffiths, M. J. D., M. Messent, R. J. MacAllister, and T. W. Evans. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110: 963-968, 1993.
16. Griswold, D. E., L. M. Hillegas, D. E. Hill, J. W. Egan, and E. F. Smith. Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissue. J. Pharmacol. Methods 20: 225-235, 1988.
17. Harbrecht, B. G., T. R. Billiar, J. Stadler, A. J. Demetris, J. Ochoa, R. D. Curran, and R. L. Simmons. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J. Leukocyte Biol. 52: 390-394, 1992.
18. 2+. Biochem. J. 270: 351-356, 1990.
19. G-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta. Biochem. Biophys. Res. Commun. 199: 147-154, 1994.
20. Kilbourn, R. G., and P. Belloni. Endothelial cell production of nitrogen oxides in response to interferon γ in combination with tumor necrosis factor, interleukin-1 or endotoxin. J. Natl. Cancer Inst. 82: 772-776, 1990.
21. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA 87: 3629-3632, 1990.
22. Klabunde, R. E., and A. F. Coston. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock. Shock 3: 73-78, 1995.
23. G-monomethyl-L-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem. Biophys. Res. Commun. 178: 1135-1140, 1991.
24. Knowles, R. G., M. Merrett, M. Slater, and S. Moncada. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat. Biochem. J. 270: 833-836, 1990.
25. Kolls, J., J. Xie, R. LeBlanc, T. Malinski, S. Nelson, W. Summer, and S. S. Greenberg. Rapid induction of messenger RNA for nitric oxide synthase II in rat neutrophils in vivo by endotoxin and its suppression by prednisolone. Proc. Soc. Exp. Biol. Med. 205: 220-225, 1994.
26. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q.-W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81: 641-650, 1995.
27. Minnard, E. A., J. Shou, H. Naama, A. Cech, H. Gallagher, and J. M. Daly. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch. Surg. 129: 142-148, 1994.
28. Neugebauer, E. A., and J. W. Holaday. Handbook of Mediators in Septic Shock, Boca Raton, FL: CRC, 1993.
29. Petros, A., G. Lamb, A. Leone, S. Moncada, D. Bennet, and P. Vallance. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc. Res. 28: 34-39, 1994.
30. Radomski, M. W., R. M. J. Palmer, and S. Moncada. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol. 92: 639-646, 1987.
31. Robertson, F. M., P. J. Offner, D. P. Ciceri, W. K. Becker, and B. A. Pruitt. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch. Surg. 129: 149-156, 1994.
32. Salvemini, D., S. L. Settle, J. L. Masferrer, K. Seibert, M. G. Currie, and P. Needleman. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br. J. Pharmacol. 114: 1171-1178, 1995.
33. 2+-independent nitric oxide synthase in the myocardium. Br. J. Pharmacol. 105: 575-580, 1992.
34. Szabo, C., J. A. Mitchell, C. Thiemermann, and J. R. Vane. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108: 786-789, 1993.
35. Szabo, C., G. J. Southan, and C. Thiemermann. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor or inducible nitric oxide synthase. Proc. Natl. Acad. Sci. USA 91: 12472-12476, 1994.
36. Thiemermann, C., and J. Vane. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur. J. Pharmacol. 182: 591-595, 1990.
37. Wong, P. Y.-K., G. Yue, K. Yin, M. Miyasaka, C. L. Lane, A. M. Manning, D. C. Anderson, and F. F. Sun. Antibodies to intercellular adhesion molecule-1 ameliorate the inflammatory response in acetic acid-induced inflammatory bowel disease. J. Pharmacol. Exp. Ther. 274: 475-480, 1995.